S

Sosei Group Corp
TSE:4565

Watchlist Manager
Sosei Group Corp
TSE:4565
Watchlist
Price: 1 033 JPY 1.08% Market Closed
Market Cap: 92.9B JPY
Have any thoughts about
Sosei Group Corp?
Write Note

Sosei Group Corp
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sosei Group Corp
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
S
Sosei Group Corp
TSE:4565
Other Long-Term Assets
ÂĄ3.9B
CAGR 3-Years
571%
CAGR 5-Years
68%
CAGR 10-Years
15%
Takeda Pharmaceutical Co Ltd
TSE:4502
Other Long-Term Assets
ÂĄ423.3B
CAGR 3-Years
-1%
CAGR 5-Years
12%
CAGR 10-Years
6%
Daiichi Sankyo Co Ltd
TSE:4568
Other Long-Term Assets
ÂĄ476.6B
CAGR 3-Years
41%
CAGR 5-Years
36%
CAGR 10-Years
12%
Otsuka Holdings Co Ltd
TSE:4578
Other Long-Term Assets
ÂĄ179.6B
CAGR 3-Years
45%
CAGR 5-Years
34%
CAGR 10-Years
15%
Chugai Pharmaceutical Co Ltd
TSE:4519
Other Long-Term Assets
ÂĄ129.9B
CAGR 3-Years
18%
CAGR 5-Years
13%
CAGR 10-Years
13%
Astellas Pharma Inc
TSE:4503
Other Long-Term Assets
ÂĄ79.7B
CAGR 3-Years
7%
CAGR 5-Years
-5%
CAGR 10-Years
3%
No Stocks Found

Sosei Group Corp
Glance View

Market Cap
92.9B JPY
Industry
Pharmaceuticals

Sosei Group Corp. engages in the discovery, design, and development of medicines targeting G protein-coupled receptors (GPCRs). The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 198 full-time employees. The company went IPO on 2004-07-29. The pharmaceutical business is engaged in the research, development and sales of medicines, the management of regenerative medical funds, the investment in bio venture companies related to regenerative medicine, the overseas development by licensing, the promotion of commercialization, the structural analysis of GPCR, the initial lead compound creation, the candidate search by proprietary StaR technology, as well as structural base of new drugs using GPCR related basic technology drug discovery, screening, promotion of antibody drug research and development.

Intrinsic Value
1 330.98 JPY
Undervaluation 22%
Intrinsic Value
Price
S

See Also

What is Sosei Group Corp's Other Long-Term Assets?
Other Long-Term Assets
3.9B JPY

Based on the financial report for Sep 30, 2024, Sosei Group Corp's Other Long-Term Assets amounts to 3.9B JPY.

What is Sosei Group Corp's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
15%

Over the last year, the Other Long-Term Assets growth was 95%. The average annual Other Long-Term Assets growth rates for Sosei Group Corp have been 571% over the past three years , 68% over the past five years , and 15% over the past ten years .

Back to Top